| Dr Shante D Bennett, MD | |
|
503 North 21st St, Camp Hill, PA 17011 | |
| (717) 972-4379 | |
| (717) 972-4640 |
| Full Name | Dr Shante D Bennett |
|---|---|
| Gender | Female |
| Speciality | Diagnostic Radiology |
| Experience | 13 Years |
| Location | 503 North 21st St, Camp Hill, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396081857 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | MT200201 (Pennsylvania) | Secondary |
| 2085R0204X | Radiology - Vascular & Interventional Radiology | MD463798 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Pinnacle Health Hospitals | Harrisburg, PA | Hospital |
| Carlisle Regional Medical Center | Carlisle, PA | Hospital |
| Holy Spirit Hospital | Camp hill, PA | Hospital |
| Upmc Memorial | York, PA | Hospital |
| Upmc Pinnacle Hanover | Hanover, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Quantum Imaging And Therapeutic Associates Inc | 1355254129 | 70 |
| Penn State Health Community Medical Group Llc | 8729351077 | 646 |
News Archive
UK-based Olberon Ltd will showcase its growing portfolio of differentiating aids for improving venous access success at MEDICA 2015 - the world's largest medical trade fair.
Seeking new treatments to slow the progression of Alzheimer's disease, researchers found the blood pressure drug nilvadipine increased blood flow to the brain's memory and learning center among people with Alzheimer's disease without affecting other parts of the brain, according to new research in the American Heart Association's journal Hypertension.
Biochips are essentially tiny laboratories designed to function inside living organisms, and they are driving next-generation DNA sequencing technologies.
A candidate dengue vaccine developed by scientists at the National Institutes of Health (NIH) has been found to be safe and to stimulate a strong immune response in most vaccine recipients, according to results from an early-stage clinical trial sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH. The trial results were published online on January 17 in the Journal of Infectious Diseases.
The U.S. Food and Drug Administration today licensed for marketing the first product in the United States intended to protect people with hereditary angioedema (HAE), a rare and potentially life-threatening genetic disease. HAE affects about 6,000 to 10,000 individuals in the United States.
› Verified 4 days ago
| Entity Name | Quantum Imaging & Therapeutic Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609863893 PECOS PAC ID: 1355254129 Enrollment ID: O20031107000322 |
News Archive
UK-based Olberon Ltd will showcase its growing portfolio of differentiating aids for improving venous access success at MEDICA 2015 - the world's largest medical trade fair.
Seeking new treatments to slow the progression of Alzheimer's disease, researchers found the blood pressure drug nilvadipine increased blood flow to the brain's memory and learning center among people with Alzheimer's disease without affecting other parts of the brain, according to new research in the American Heart Association's journal Hypertension.
Biochips are essentially tiny laboratories designed to function inside living organisms, and they are driving next-generation DNA sequencing technologies.
A candidate dengue vaccine developed by scientists at the National Institutes of Health (NIH) has been found to be safe and to stimulate a strong immune response in most vaccine recipients, according to results from an early-stage clinical trial sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH. The trial results were published online on January 17 in the Journal of Infectious Diseases.
The U.S. Food and Drug Administration today licensed for marketing the first product in the United States intended to protect people with hereditary angioedema (HAE), a rare and potentially life-threatening genetic disease. HAE affects about 6,000 to 10,000 individuals in the United States.
› Verified 4 days ago
| Entity Name | Geisinger Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366493868 PECOS PAC ID: 5395657001 Enrollment ID: O20040130000518 |
News Archive
UK-based Olberon Ltd will showcase its growing portfolio of differentiating aids for improving venous access success at MEDICA 2015 - the world's largest medical trade fair.
Seeking new treatments to slow the progression of Alzheimer's disease, researchers found the blood pressure drug nilvadipine increased blood flow to the brain's memory and learning center among people with Alzheimer's disease without affecting other parts of the brain, according to new research in the American Heart Association's journal Hypertension.
Biochips are essentially tiny laboratories designed to function inside living organisms, and they are driving next-generation DNA sequencing technologies.
A candidate dengue vaccine developed by scientists at the National Institutes of Health (NIH) has been found to be safe and to stimulate a strong immune response in most vaccine recipients, according to results from an early-stage clinical trial sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH. The trial results were published online on January 17 in the Journal of Infectious Diseases.
The U.S. Food and Drug Administration today licensed for marketing the first product in the United States intended to protect people with hereditary angioedema (HAE), a rare and potentially life-threatening genetic disease. HAE affects about 6,000 to 10,000 individuals in the United States.
› Verified 4 days ago
| Entity Name | University Of Pittsburgh Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619935004 PECOS PAC ID: 8729990239 Enrollment ID: O20040308000883 |
News Archive
UK-based Olberon Ltd will showcase its growing portfolio of differentiating aids for improving venous access success at MEDICA 2015 - the world's largest medical trade fair.
Seeking new treatments to slow the progression of Alzheimer's disease, researchers found the blood pressure drug nilvadipine increased blood flow to the brain's memory and learning center among people with Alzheimer's disease without affecting other parts of the brain, according to new research in the American Heart Association's journal Hypertension.
Biochips are essentially tiny laboratories designed to function inside living organisms, and they are driving next-generation DNA sequencing technologies.
A candidate dengue vaccine developed by scientists at the National Institutes of Health (NIH) has been found to be safe and to stimulate a strong immune response in most vaccine recipients, according to results from an early-stage clinical trial sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH. The trial results were published online on January 17 in the Journal of Infectious Diseases.
The U.S. Food and Drug Administration today licensed for marketing the first product in the United States intended to protect people with hereditary angioedema (HAE), a rare and potentially life-threatening genetic disease. HAE affects about 6,000 to 10,000 individuals in the United States.
› Verified 4 days ago
| Entity Name | Spirit Physician Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093013328 PECOS PAC ID: 8022922202 Enrollment ID: O20040402000053 |
News Archive
UK-based Olberon Ltd will showcase its growing portfolio of differentiating aids for improving venous access success at MEDICA 2015 - the world's largest medical trade fair.
Seeking new treatments to slow the progression of Alzheimer's disease, researchers found the blood pressure drug nilvadipine increased blood flow to the brain's memory and learning center among people with Alzheimer's disease without affecting other parts of the brain, according to new research in the American Heart Association's journal Hypertension.
Biochips are essentially tiny laboratories designed to function inside living organisms, and they are driving next-generation DNA sequencing technologies.
A candidate dengue vaccine developed by scientists at the National Institutes of Health (NIH) has been found to be safe and to stimulate a strong immune response in most vaccine recipients, according to results from an early-stage clinical trial sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH. The trial results were published online on January 17 in the Journal of Infectious Diseases.
The U.S. Food and Drug Administration today licensed for marketing the first product in the United States intended to protect people with hereditary angioedema (HAE), a rare and potentially life-threatening genetic disease. HAE affects about 6,000 to 10,000 individuals in the United States.
› Verified 4 days ago
| Entity Name | Penn State Health Community Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861988644 PECOS PAC ID: 8729351077 Enrollment ID: O20170907002279 |
News Archive
UK-based Olberon Ltd will showcase its growing portfolio of differentiating aids for improving venous access success at MEDICA 2015 - the world's largest medical trade fair.
Seeking new treatments to slow the progression of Alzheimer's disease, researchers found the blood pressure drug nilvadipine increased blood flow to the brain's memory and learning center among people with Alzheimer's disease without affecting other parts of the brain, according to new research in the American Heart Association's journal Hypertension.
Biochips are essentially tiny laboratories designed to function inside living organisms, and they are driving next-generation DNA sequencing technologies.
A candidate dengue vaccine developed by scientists at the National Institutes of Health (NIH) has been found to be safe and to stimulate a strong immune response in most vaccine recipients, according to results from an early-stage clinical trial sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH. The trial results were published online on January 17 in the Journal of Infectious Diseases.
The U.S. Food and Drug Administration today licensed for marketing the first product in the United States intended to protect people with hereditary angioedema (HAE), a rare and potentially life-threatening genetic disease. HAE affects about 6,000 to 10,000 individuals in the United States.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Shante D Bennett, MD 100 North Academy Ave, Danville, PA 17822-4903 Ph: (717) 972-4379 | Dr Shante D Bennett, MD 503 North 21st St, Camp Hill, PA 17011 Ph: (717) 972-4379 |
News Archive
UK-based Olberon Ltd will showcase its growing portfolio of differentiating aids for improving venous access success at MEDICA 2015 - the world's largest medical trade fair.
Seeking new treatments to slow the progression of Alzheimer's disease, researchers found the blood pressure drug nilvadipine increased blood flow to the brain's memory and learning center among people with Alzheimer's disease without affecting other parts of the brain, according to new research in the American Heart Association's journal Hypertension.
Biochips are essentially tiny laboratories designed to function inside living organisms, and they are driving next-generation DNA sequencing technologies.
A candidate dengue vaccine developed by scientists at the National Institutes of Health (NIH) has been found to be safe and to stimulate a strong immune response in most vaccine recipients, according to results from an early-stage clinical trial sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH. The trial results were published online on January 17 in the Journal of Infectious Diseases.
The U.S. Food and Drug Administration today licensed for marketing the first product in the United States intended to protect people with hereditary angioedema (HAE), a rare and potentially life-threatening genetic disease. HAE affects about 6,000 to 10,000 individuals in the United States.
› Verified 4 days ago
Harold Steven Rabin, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 503 N 21st St, Camp Hill, PA 17011 Phone: 717-763-2685 Fax: 717-763-2963 | |
Richard Philip Stewart, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 503 N 21st St, Camp Hill, PA 17011 Phone: 717-763-2685 Fax: 717-763-2963 | |
Bertrand Giulian, Radiology Medicare: Not Enrolled in Medicare Practice Location: 649 Saint Johns Dr, Camp Hill, PA 17011 Phone: 717-737-5628 | |
Barry Leon Levin, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 503 N 21st St, Camp Hill, PA 17011 Phone: 717-763-2685 Fax: 717-763-2963 | |
Francis Joseph Gallia, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 503 N 21st St, Camp Hill, PA 17011 Phone: 717-763-2685 Fax: 717-763-2963 |